FDA Commissioner Marty Makary promises review of abortion pill’s safety
Washington Times
Valerie Richardson
Food and Drug Administration Commissioner Marty Makary said he plans to undertake a review of mifepristone, also known as the abortion pill, amid research showing that the drug is more dangerous than the agency has previously reported.
The FDA approved mifepristone for use in elective pregnancy termination in 2000. Still, Dr. Makary confirmed Monday in a letter to Sen. Josh Hawley, Missouri Republican, that the drug is once again on the agency’s radar.
“As with all drugs, FDA continues to closely monitor the postmarketing safety data on mifepristone for the medical termination of early pregnancy,” Dr. Makary said in the letter. “As the Commissioner of Food and Drugs, I am committed to conducting a review of mifepristone and working with the professional career scientists at the Agency who review this data.”